Matches in SemOpenAlex for { <https://semopenalex.org/work/W2925809780> ?p ?o ?g. }
- W2925809780 endingPage "496" @default.
- W2925809780 startingPage "496" @default.
- W2925809780 abstract ": Treatment of advanced gastric cancer patients with current standard chemotherapeutic agents frequently results in resistance, leading to poor overall survival. However, there has been no success in developing strategies to overcome it. We showed the expression levels of both β-catenin and RAS were significantly increased and correlated in tissues of 756 gastric cancer (GC) patients and tissues of primary- and acquired-resistance patient-derived xenograft tumors treated with 5-fluorouracil and oxaliplatin modulated with leucovorin (FOLFOX). On the basis of our previous studies, where small molecules to suppress colorectal cancer (CRC) via degrading both β-catenin and RAS were developed, we tested the effectiveness of KYA1797K, a representative compound functioning by binding axin, in the growth of GC cells. The efficacy test of the drugs using gastric tumor organoids of Apc1638N mice showed that the CD44 and ALDH1A3 cancer stem cell markers were induced by FOLFOX, but not by KYA1797K. KYA1797K also efficiently suppressed tumors generated by re-engrafting the FOLFOX-resistant patient-derived xenograft (PDX) tumors, which also showed resistance to paclitaxel. Overall, the small-molecule approach degrading both β-catenin and RAS has potential as a therapeutic strategy for treating GC patients resistant to current standard chemotherapies." @default.
- W2925809780 created "2019-04-11" @default.
- W2925809780 creator A5000246711 @default.
- W2925809780 creator A5004667276 @default.
- W2925809780 creator A5020332540 @default.
- W2925809780 creator A5023766676 @default.
- W2925809780 creator A5032767655 @default.
- W2925809780 creator A5033033849 @default.
- W2925809780 creator A5055083737 @default.
- W2925809780 creator A5057610578 @default.
- W2925809780 creator A5063887075 @default.
- W2925809780 creator A5064637828 @default.
- W2925809780 creator A5067451348 @default.
- W2925809780 creator A5067941687 @default.
- W2925809780 creator A5084704011 @default.
- W2925809780 date "2019-04-08" @default.
- W2925809780 modified "2023-10-13" @default.
- W2925809780 title "A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS" @default.
- W2925809780 cites W1534578968 @default.
- W2925809780 cites W1576367693 @default.
- W2925809780 cites W1902808781 @default.
- W2925809780 cites W1965917470 @default.
- W2925809780 cites W1974377924 @default.
- W2925809780 cites W1983883123 @default.
- W2925809780 cites W1995266071 @default.
- W2925809780 cites W1996179819 @default.
- W2925809780 cites W1996277017 @default.
- W2925809780 cites W2006239354 @default.
- W2925809780 cites W2006434892 @default.
- W2925809780 cites W2010269182 @default.
- W2925809780 cites W2051357618 @default.
- W2925809780 cites W2061130074 @default.
- W2925809780 cites W2064827438 @default.
- W2925809780 cites W2069378448 @default.
- W2925809780 cites W2092024871 @default.
- W2925809780 cites W2097959454 @default.
- W2925809780 cites W2100305481 @default.
- W2925809780 cites W2105947020 @default.
- W2925809780 cites W2106300588 @default.
- W2925809780 cites W2106787323 @default.
- W2925809780 cites W2118474093 @default.
- W2925809780 cites W2121964616 @default.
- W2925809780 cites W2124715710 @default.
- W2925809780 cites W2126547130 @default.
- W2925809780 cites W2131695415 @default.
- W2925809780 cites W2140729960 @default.
- W2925809780 cites W2143219457 @default.
- W2925809780 cites W2153128764 @default.
- W2925809780 cites W2154431984 @default.
- W2925809780 cites W2169580709 @default.
- W2925809780 cites W2223549218 @default.
- W2925809780 cites W2244032970 @default.
- W2925809780 cites W2322937685 @default.
- W2925809780 cites W2331031707 @default.
- W2925809780 cites W2412313638 @default.
- W2925809780 cites W2421886702 @default.
- W2925809780 cites W2531499154 @default.
- W2925809780 cites W2550335841 @default.
- W2925809780 cites W2788735115 @default.
- W2925809780 cites W2804957989 @default.
- W2925809780 cites W74841586 @default.
- W2925809780 doi "https://doi.org/10.3390/cancers11040496" @default.
- W2925809780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6521309" @default.
- W2925809780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30965636" @default.
- W2925809780 hasPublicationYear "2019" @default.
- W2925809780 type Work @default.
- W2925809780 sameAs 2925809780 @default.
- W2925809780 citedByCount "9" @default.
- W2925809780 countsByYear W29258097802019 @default.
- W2925809780 countsByYear W29258097802020 @default.
- W2925809780 countsByYear W29258097802021 @default.
- W2925809780 countsByYear W29258097802023 @default.
- W2925809780 crossrefType "journal-article" @default.
- W2925809780 hasAuthorship W2925809780A5000246711 @default.
- W2925809780 hasAuthorship W2925809780A5004667276 @default.
- W2925809780 hasAuthorship W2925809780A5020332540 @default.
- W2925809780 hasAuthorship W2925809780A5023766676 @default.
- W2925809780 hasAuthorship W2925809780A5032767655 @default.
- W2925809780 hasAuthorship W2925809780A5033033849 @default.
- W2925809780 hasAuthorship W2925809780A5055083737 @default.
- W2925809780 hasAuthorship W2925809780A5057610578 @default.
- W2925809780 hasAuthorship W2925809780A5063887075 @default.
- W2925809780 hasAuthorship W2925809780A5064637828 @default.
- W2925809780 hasAuthorship W2925809780A5067451348 @default.
- W2925809780 hasAuthorship W2925809780A5067941687 @default.
- W2925809780 hasAuthorship W2925809780A5084704011 @default.
- W2925809780 hasBestOaLocation W29258097801 @default.
- W2925809780 hasConcept C121608353 @default.
- W2925809780 hasConcept C126322002 @default.
- W2925809780 hasConcept C137620995 @default.
- W2925809780 hasConcept C143998085 @default.
- W2925809780 hasConcept C1491633281 @default.
- W2925809780 hasConcept C2776694085 @default.
- W2925809780 hasConcept C2777292972 @default.
- W2925809780 hasConcept C2778260052 @default.
- W2925809780 hasConcept C2780932548 @default.
- W2925809780 hasConcept C2780962732 @default.
- W2925809780 hasConcept C30145163 @default.